PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients.
about
RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disordersEnhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for CancerTranslational control by eIF2α kinases in long-lasting synaptic plasticity and long-term memory.Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid beta (Abeta)-treated cells and in APPSLPS1 knock-in miceMetaflammasome components in the human brain: a role in dementia with Alzheimer's pathology?Genome-wide analysis of H4K5 acetylation associated with fear memory in micedsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's diseaseMammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?Roles of AMP-activated protein kinase in Alzheimer's disease.Activation of mTOR: a culprit of Alzheimer's disease?Validation of a commercially available anti-REDD1 antibody using RNA interference and REDD1-/- mouse embryonic fibroblastsThere is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer's disease.PKR involvement in Alzheimer's diseaseRTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.
P2860
Q28395230-968FB437-F3B8-4E3C-B867-930C9DAD46D8Q29147555-0C5E5EE9-229F-4B41-AED0-FE3AF96091B5Q30429927-9C487CA3-D020-453E-86BB-B67DAACE7FF8Q33569701-F5454E1A-3F27-4EB5-8E7C-ECC89D27B4D8Q33625557-13D9CB30-F7A0-42F0-9DA7-26D111A3170EQ34910865-D069FF31-CE78-4390-9FDF-381FB6AE4008Q36432681-1BA0D4F7-132A-49F0-ABB6-79B5BC35A3A0Q37310632-14012474-A82B-44D7-B1F2-C1E4A5F0FB2BQ37985671-5232EFA1-AE0F-4637-B2D9-0135E178F08CQ37988399-E9064C75-3365-4E83-849A-CDE116C841A1Q38443497-2DED0282-BB1D-4201-8B66-1F641914358EQ38762707-C22A05A7-08B3-4256-A60A-5800395DD5BCQ41381108-19F9559F-587A-4CCA-B0FA-2D5A551F09F0Q42371247-7936895F-0511-4936-BAE0-C65678CC78AFQ48200890-F3A3E01A-CAF7-4F0B-B437-40D80697F27D
P2860
PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
PKR, a cognitive decline bioma ...... in lymphocytes of AD patients.
@en
PKR, a cognitive decline bioma ...... in lymphocytes of AD patients.
@nl
type
label
PKR, a cognitive decline bioma ...... in lymphocytes of AD patients.
@en
PKR, a cognitive decline bioma ...... in lymphocytes of AD patients.
@nl
prefLabel
PKR, a cognitive decline bioma ...... in lymphocytes of AD patients.
@en
PKR, a cognitive decline bioma ...... in lymphocytes of AD patients.
@nl
P2093
P2860
P1476
PKR, a cognitive decline bioma ...... in lymphocytes of AD patients.
@en
P2093
Guillaume Laborie
Guylène Page
Marc Paccalin
Milena Damjanac
Stéphanie Ragot
P2860
P304
P356
10.1111/J.1582-4934.2009.00688.X
P577
2009-02-04T00:00:00Z